Jin Medical International Capital Expenditures (CapEx) Growth & History (ZJYL)
Jin Medical International's capital expenditures (capex) was $6.6M for fiscal 2025.
View full Jin Medical International company overviewJin Medical International annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-09-30 | $6.6M | $6.5M | +4473.88% |
| 2024 | 2024-09-30 | $144,949 | $31,012 | +27.22% |
| 2023 | 2023-09-30 | $113,937 | $73,771 | +183.67% |
| 2022 | 2022-09-30 | $40,166 | −$2,715 | −6.33% |
| 2021 | 2021-09-30 | $42,881 | — | — |
Jin Medical International capital expenditures (capex) trends
Between the periods ended 2021-09-30 and 2025-09-30, Jin Medical International's capital expenditures (capex) increased from $42,881 to $6.6M, a change of $6.6M.
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Jin Medical International source filings ↗